Companies / Contineum Therapeutics, Inc. / Activity
Activity — Contineum Therapeutics, Inc.
5 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q4 2025 as of | Boxer Capital Management, LLC 13F manager | New | Common stock | $5.65M | +494K | 494,000 1.31% of shares | medium |
| Q2 2026 as of | Deutsche Bank AG 13F manager | New | Common stock | $429.7K | +26K | 26,216 0.07% of shares | low |
| Q1 2026 as of | CPPIB Crestone Peak Resources Canada Inc. 13F manager | New | Common stock | $269.0K | +21K | 20,600 0.05% of shares | low |
| Q4 2025 as of | Persistent Asset Partners Ltd 13F manager | New | Common stock | $158.3K | +14K | 13,853 0.04% of shares | low |
| Q2 2024 as of | Barclays PLC 13F manager | New | Common stock | $42.0K | +2K | 2,383 <0.01% of shares | low |